4.7 Review

Antiretroviral Treatment of Adult HIV Infection 2012 Recommendations of the International Antiviral Society-USA Panel

Journal

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Volume 308, Issue 4, Pages 387-402

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jama.2012.7961

Keywords

-

Funding

  1. Boehringer-Ingelheim (BI)
  2. Cepheid
  3. GeoVax
  4. Gilead
  5. GlaxoSmithKline (GSK)
  6. Kaketsuken
  7. Kowa Research Institute
  8. Merck Research Laboratories
  9. Myriad
  10. Peregrine
  11. Pfizer
  12. Progenics
  13. Roche Molecular Systems
  14. Theratechnologies
  15. Tibotec
  16. Tobira
  17. Viiv Healthcare
  18. MSD
  19. BMS
  20. Abbott
  21. GSK
  22. Janssen-Cilag
  23. Merck
  24. Janssen
  25. IAS-USA
  26. Health Resources and Services Administration (HRSA)
  27. National Resource Center of the AIDS Education and Treatment Centers (via funding from HRSA)

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available